- Home
- BODI vs TPST Comparison
BODI vs TPST Comparison
Compare BODI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- TPST
- Stock Information
- Founded
- BODI 1998
- TPST 2011
- Country
- BODI United States
- TPST United States
- Employees
- BODI N/A
- TPST N/A
- Industry
- BODI Industrial Machinery/Components
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- TPST Health Care
- Exchange
- BODI Nasdaq
- TPST Nasdaq
- Market Cap
- BODI 28.3M
- TPST 24.5M
- IPO Year
- BODI N/A
- TPST N/A
- Fundamental
- Price
- BODI $3.65
- TPST $8.25
- Analyst Decision
- BODI Strong Buy
- TPST Hold
- Analyst Count
- BODI 3
- TPST 3
- Target Price
- BODI $10.67
- TPST $30.00
- AVG Volume (30 Days)
- BODI 27.0K
- TPST 52.1K
- Earning Date
- BODI 08-05-2025
- TPST 05-13-2025
- Dividend Yield
- BODI N/A
- TPST N/A
- EPS Growth
- BODI N/A
- TPST N/A
- EPS
- BODI N/A
- TPST N/A
- Revenue
- BODI $371,113,000.00
- TPST N/A
- Revenue This Year
- BODI N/A
- TPST N/A
- Revenue Next Year
- BODI N/A
- TPST N/A
- P/E Ratio
- BODI N/A
- TPST N/A
- Revenue Growth
- BODI N/A
- TPST N/A
- 52 Week Low
- BODI $3.38
- TPST $5.35
- 52 Week High
- BODI $9.40
- TPST $44.33
- Technical
- Relative Strength Index (RSI)
- BODI 39.67
- TPST 66.61
- Support Level
- BODI $3.50
- TPST $5.92
- Resistance Level
- BODI $3.89
- TPST $8.89
- Average True Range (ATR)
- BODI 0.30
- TPST 0.48
- MACD
- BODI 0.03
- TPST 0.26
- Stochastic Oscillator
- BODI 24.04
- TPST 78.41
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.